NVDA
NVIDIA Corporation
NVDA has the edge over PSFE overall, supported by stronger fundamentals and stronger valuation.
PSFE
Paysafe Limited
PSFE's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
PSFE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Healthy | |
| Weak |
PSFE's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are weak.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
PSFE PE Valuation
PSFE has no meaningful PE right now: it lost money over the past year.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
PSFE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
PSFE has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over PSFE on earnings quality, reporting a profit while its opponent remains loss making.
PSFE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.12 | — |
| Q3 2026 | -$7.02 | -$4.86 |
| Q2 2026 | -$3.80 | -$2.95 |
| Q1 2026 | -$3.52 | -$3.50 |
| Q4 2025 | -$3.14 | -972% |
| Q3 2025 | -$2.16 | -$1.78 |
| Q2 2025 | -$0.85 | -$0.64 |
| Q1 2025 | -$0.02 | +$0.20 |
| Q4 2024 | $0.36 | +$0.69 |
PSFE lost $7.02 per share over the past year, and its loss has widened in each of the last seven quarters.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over PSFE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over PSFE on profitability, with a higher operating margin.
PSFE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $439.6M | +1.3% |
| Q2 2026 | $447.4M | +4.5% |
| Q1 2026 | $442.7M | +10% |
| Q4 2025 | $438.4M | +4.4% |
| Q3 2025 | $433.8M | +1.6% |
| Q2 2025 | $428.2M | -2.7% |
| Q1 2025 | $401M | -4% |
| Q4 2024 | $420.1M | +1.3% |
PSFE's revenue has grown year over year for five quarters in a row: $440M last quarter, up 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -42% | -51 points |
| Q2 2026 | -2.8% | -7.6 points |
| Q1 2026 | 0.2% | -2.3 points |
| Q4 2025 | 0.5% | -6.6 points |
| Q3 2025 | 9% | +0.9 points |
| Q2 2025 | 4.8% | -3.5 points |
| Q1 2025 | 2.6% | -5.3 points |
| Q4 2024 | 7% | -4.1 points |
PSFE's operating margin was −42% last quarter, down 51 points from the same quarter a year ago, near the bottom of its range since 2019.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over PSFE on cash flow, with more consistent year-over-year improvement.
PSFE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $28.4M | -58% |
| Q2 2026 | $24.5M | -33% |
| Q1 2026 | $63.3M | +32% |
| Q4 2025 | $71.8M | +32% |
| Q3 2025 | $66.9M | -15% |
| Q2 2025 | $36.8M | -26% |
| Q1 2025 | $48.2M | -13% |
| Q4 2024 | $54.4M | -91% |
PSFE still generates free cash flow, though less than at its 2022 peak: $188M over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
PSFE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -50.2K shares |
| 1 year | -9.3% | -5.4M shares |
| 3 years | -15% | -9.4M shares |
| 5 years | -13% | -8.1M shares |
| Available history | -13% | -8.1M shares |
PSFE has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over PSFE on leverage, with a lower net debt burden relative to earnings.
PSFE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 27.8x | High |
| Q2 2026 | 7.4x | High |
| Q1 2026 | 6.6x | High |
| Q4 2025 | 6.8x | High |
| Q3 2025 | 6.1x | High |
| Q2 2025 | 6.2x | High |
| Q1 2025 | 5.6x | High |
| Q4 2024 | 5.3x | High |
PSFE's net debt is more than 20 years of its operating earnings (EBITDA), up from 6.1 years a year ago.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
PSFE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.0 | Neutral |
| Stochastic | 18.1 | Oversold |
PSFE's weekly RSI is 32 (neutral) and its Stochastic is 18 (oversold).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
PSFE PE vs Technology Sector
PSFE has no meaningful PE right now: it lost money over the past year.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over PSFE on trend strength, trading above more of its moving averages.
PSFE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.65 | 32% below |
| 20 week MA | $6.64 | 42% below |
| 50 week MA | $7.17 | 46% below |
| 100 week MA | $10.7 | 64% below |
| 200 week MA | $13.3 | 71% below |
PSFE is in a downtrend: it's below all five of its weekly moving averages, and 71% below its 200-week average.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over PSFE on returns for 2026, with the stronger performance.
PSFE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $119.4 | $182.8 | +53% |
| 2021 | $182.8 | $48.8 | -73% |
| 2022 | $48.8 | $12.8 | -74% |
| 2023 | $12.8 | $12.8 | -0.2% |
| 2024 | $12.8 | $17.4 | +36% |
| 2025 | $17.4 | $8.03 | -54% |
| 2026 YTD | $8.03 | $3.87 | -52% |
PSFE has finished lower in four of the last six years. It's down 52% so far in 2026.